Myelofibrosis natural history, complications and prognosis: Difference between revisions
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Myelofibrosis}} | {{Myelofibrosis}} | ||
{{CMG}} | {{CMG}}{{AE}}{{SR}} | ||
==Overview== | ==Overview== | ||
==Natural History | ==Natural History== | ||
== | |||
==Complications== | |||
Common complications of myelofibrosis include: | |||
*[[Acute myelogenous leukemia]] | |||
*[[Infections]] | |||
*[[Bleeding]] | |||
*[[Blood clots]] | |||
*[[Hepatic failure]] | |||
==Prognosis== | |||
Myelofibrosis leads to progressive bone marrow failure. The mean survival is five years and causes of death include infection, bleeding, organ failure, portal hypertension, and leukemic transformation. | Myelofibrosis leads to progressive bone marrow failure. The mean survival is five years and causes of death include infection, bleeding, organ failure, portal hypertension, and leukemic transformation. | ||
Line 15: | Line 21: | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category: | [[Category:Oncology]] | ||
[[Category:Hematology]] | [[Category:Hematology]] | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} |
Revision as of 16:24, 7 March 2016
Myelofibrosis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Myelofibrosis natural history, complications and prognosis On the Web |
American Roentgen Ray Society Images of Myelofibrosis natural history, complications and prognosis |
FDA on Myelofibrosis natural history, complications and prognosis |
CDC on Myelofibrosis natural history, complications and prognosis |
Myelofibrosis natural history, complications and prognosis in the news |
Blogs on Myelofibrosis natural history, complications and prognosis |
Risk calculators and risk factors for Myelofibrosis natural history, complications and prognosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sujit Routray, M.D. [2]
Overview
Natural History
Complications
Common complications of myelofibrosis include:
Prognosis
Myelofibrosis leads to progressive bone marrow failure. The mean survival is five years and causes of death include infection, bleeding, organ failure, portal hypertension, and leukemic transformation.